A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkers

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Essaghir, Ahmed ^a   Demoulin, Jean Baptiste ^a  

^a DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MEMBRANE PROTEIN; PROTEIN TFRC; PROTEOME; SCATTER FACTOR RECEPTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SURVIVAL; CHROMOSOME ANALYSIS; COPY NUMBER VARIATION; DATA BASE; FUNCTIONAL PROTEOMICS; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE REGULATORY NETWORK; HUMAN; HYPOXIA; INFLAMMATORY DISEASE; INTEGRATIVE MEDICINE; MINIMAL CONNECTED NETWORK; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; TRANSCRIPTION REGULATION; TUMOR CLASSIFICATION; WEB BROWSER;

CELL LINE, TUMOR; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862642252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039666     Document Type: Article

References (72)

1. Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, et al. (2010) Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol 2: 125-148. doi:http://dx.doi.org/10.1177/1758834009360519.
2. Buseman CM, Wright WE, Shay JW, (2011) Is telomerase a viable target in cancer? Mutat Res 730: 90-7. doi:http://dx.doi.org/10.1016/j.mrfmmm.2011.07.006.
3. Xu T, Lu B, Tai Y-C, Goldkorn A, (2010) A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res 70: 6420-6426. doi:http://dx.doi.org/10.1158/0008-5472.CAN-10-0686.
4. Cho-Chung YS, (2006) Autoantibody biomarkers in the detection of cancer. Biochim Biophys Acta 1762: 587-591. doi:http://dx.doi.org/10.1016/j.bbadis.2006.04.001.
5. Nesterova M, Johnson N, Cheadle C, Cho-Chung YS, (2006) Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 1762: 398-403. doi:http://dx.doi.org/10.1016/j.bbadis.2005.12.010.
6. Radu A, Pichon C, Camparo P, Antoine M, Allory Y, et al. (2010) Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 363: 1621-1630. doi:http://dx.doi.org/10.1056/NEJMoa1001283.
7. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, et al. (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031.
8. Levenson VV, (2010) DNA methylation as a universal biomarker. Expert Rev Mol Diagn 10: 481-488. doi:http://dx.doi.org/10.1586/erm.10.17.
9. Levenson VV, Melnikov AA, (2011) The MethDet: a technology for biomarker development. Expert Rev Mol Diagn 11: 807-812. doi:http://dx.doi.org/10.1586/erm.11.74.
10. Noguchi K, Isogai M, Kuwada E, Noguchi A, Goto S, et al. (2004) Detection of anti-HLA-F antibodies in sera from cancer patients. Anticancer Res 24: 3387-3392.
11. Polanski M, Anderson NL, (2007) A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1: 1-48.
12. Dawany NB, Dampier WN, Tozeren A, (2011) Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types. Int J Cancer 128: 2881-2891.
13. Basil CF, Zhao Y, Zavaglia K, Jin P, Panelli MC, et al. (2006) Common cancer biomarkers. Cancer Res 66: 2953-2961. doi:http://dx.doi.org/10.1158/0008-5472.CAN-05-3433.
14. Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI, (2008) Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS One 3: e3661. doi http://dx.doi.org/10.1371/journal.pone.0003661.
15. Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, et al. (2007) A map of human cancer signaling. Mol Syst Biol 3: 152. doi:http://dx.doi.org/10.1038/msb4100200.
16. Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 12: 715-723. doi:http://dx.doi.org/10.1038/ni.2060.
17. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, et al. (2011) TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71: 5606-5610. doi:http://dx.doi.org/10.1158/0008-5472.CAN-11-1194.
18. Zavoral M, Minarikova P, Zavada F, Salek C, Minarik M, (2011) Molecular biology of pancreatic cancer. World J Gastroenterol 17: 2897-2908. doi:http://dx.doi.org/10.3748/wjg.v17.i24.2897.
19. Steidl C, Gascoyne RD, (2011) The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 118: 2659-2669. doi:http://dx.doi.org/10.1182/blood-2011-05-326538.
20. Abel EV, Aplin AE, (2011) Finding the root of the problem: the quest to identify melanoma stem cells. Front Biosci (Schol Ed) 3: 937-945.
21. Demoulin J-B, Enarsson M, Larsson J, Essaghir A, Heldin C-H, et al. (2006) The gene expression profile of PDGF-treated neural stem cells corresponds to partially differentiated neurons and glia. Growth Factors 24: 184-196.
22. Laurenti G, Benedetti E, D'Angelo B, Cristiano L, Cinque B, et al. (2011) Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells. J Cell Biochem 112: 3891-3901. doi:http://dx.doi.org/10.1002/jcb.23323.
23. Goodarzi H, Elemento O, Tavazoie S, (2009) Revealing global regulatory perturbations across human cancers. Mol Cell 36: 900-911. doi:http://dx.doi.org/10.1016/j.molcel.2009.11.016.
24. Little JL, Wheeler FB, Koumenis C, Kridel SJ, (2008) Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death. Mol Cancer Ther 7: 3816-3824. doi:http://dx.doi.org/10.1158/1535-7163.MCT-08-0558.
25. Wilson BJ, Giguère V, (2008) Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 7: 49. doi:http://dx.doi.org/10.1186/1476-4598-7-49.
26. Deshmukh H, Yu J, Shaik J, MacDonald TJ, Perry A, et al. (2011) Identification of transcriptional regulatory networks specific to pilocytic astrocytoma. BMC Med Genomics 4: 57. doi:http://dx.doi.org/10.1186/1755-8794-4-57.
27. Gioeli D, (2011) The Dynamics of the Cell Signaling Network; Implications for Targeted Therapies. Targeted Therapies. Humana Press pp. 33-53.
28. Wu G, Feng X, Stein L, (2010) A human functional protein interaction network and its application to cancer data analysis. Genome Biol 11: R53. doi:http://dx.doi.org/10.1186/gb-2010-11-5-r53.
29. Chen L, Xuan J, Wang C, Shih I-M, Wang Y, et al. (2008) Knowledge-guided multi-scale independent component analysis for biomarker identification. BMC Bioinformatics 9: 416. doi:http://dx.doi.org/10.1186/1471-2105-9-416.
30. Essaghir A, Toffalini F, Knoops L, Kallin A, van Helden J, et al. (2010) Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res 38: e120. doi:http://dx.doi.org/10.1093/nar/gkq149.
31. Xu Y, Duanmu H, Chang Z, Zhang S, Li Z, et al. (2011) The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer. Mol Biol Rep 39: 1627-37. doi:http://dx.doi.org/10.1007/s11033-011-0902-3.
32. Tran LM, Zhang B, Zhang Z, Zhang C, Xie T, et al. (2011) Inferring causal genomic alterations in breast cancer using gene expression data. BMC Syst Biol 5: 121. doi:http://dx.doi.org/10.1186/1752-0509-5-121.
33. Pachikian BD, Essaghir A, Demoulin J-B, Neyrinck AM, Catry E, et al. (2011) Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS ONE 6: e23365. doi:10.1371/journal.pone.0023365.
34. Montano-Almendras CP, Essaghir A, Schoemans H, Varis I, Noel LA, et al. (2012) ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor proliferation and differentiation into eosinophils: role of NF-κB. Haematologica. Available:http://www.ncbi.nlm.nih.gov/pubmed/22271894. Accessed 2012 May 2.
35. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 104: 20007-20012. doi:http://dx.doi.org/10.1073/pnas.0710052104.
36. Kuiper RP, Ligtenberg MJL, Hoogerbrugge N, Geurts van Kessel A, (2010) Germline copy number variation and cancer risk. Curr Opin Genet Dev 20: 282-289. doi:10.1016/j.gde.2010.03.005.
37. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-213. doi:10.1093/nar/gkq388.
38. Minguez P, Götz S, Montaner D, Al-Shahrour F, Dopazo J, (2009) SNOW, a web-based tool for the statistical analysis of protein-protein interaction networks. Nucleic Acids Res 37: W109-W114. doi:http://dx.doi.org/10.1093/nar/gkp402.
39. Scardoni G, Petterlini M, Laudanna C, (2009) Analyzing biological network parameters with CentiScaPe. Bioinformatics 25: 2857-2859. doi:http://dx.doi.org/10.1093/bioinformatics/btp517.
40. Rodriguez-Caso C, Medina MA, Solé RV, (2005) Topology, tinkering and evolution of the human transcription factor network. FEBS J 272: 6423-6434. doi:10.1111/j.1742-4658.2005.05041x.
41. Aggarwal BB, Sung B, (2011) The relationship between inflammation and cancer is analogous to that between fuel and fire. Oncology (Williston Park) 25: 414-418.
42. Chechlinska M, Kowalewska M, Nowak R, (2010) Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer 10: 2-3. doi:http://dx.doi.org/10.1038/nrc2782.
43. Ludwig JA, Weinstein JN, (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856. doi:http://dx.doi.org/10.1038/nrc1739.
44. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905. doi:10.1038/nature08822.
45. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, et al. (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28: 1248-1250. doi:10.1038/nbt1210-1248.
46. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
47. Lefebvre C, Rieckhof G, Califano A, (2012) Reverse-engineering human regulatory networks. Wiley Interdisciplinary Reviews Systems Biology and Medicine. Available:http://www.ncbi.nlm.nih.gov/pubmed/22246697. Accessed 30 March 2012.
48. Clements J, Ward G, Kaushal A, Hi SI, Kennett C, et al. (1997) A prostate-specific antigen-like protein associated with renal cell carcinoma in women. Clin Cancer Res 3: 1427-1431.
49. Milne ANA, Sitarz R, Carvalho R, Polak MM, Ligtenberg M, et al. (2007) Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. Hum Pathol 38: 903-913. doi:http://dx.doi.org/10.1016/j.humpath.2006.12.010.
50. Chang Y-F, Hung S-H, Lee Y-J, Chen R-C, Su L-C, et al. (2011) Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum. Anal Chem 83: 5324-5328. doi:http://dx.doi.org/10.1021/ac200754x.
51. van Leenders GJLH, Sookhlall R, Teubel WJ, de Ridder CMA, Reneman S, et al. (2011) Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer. PLoS One 6: e26753. doi:http://dx.doi.org/10.1371/journal.pone.0026753.
52. Sun S, Wang Z, (2011) Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int J Cancer 129: 2337-2348. doi:http://dx.doi.org/10.1002/ijc.25927.
53. You H, Ding W, Dang H, Jiang Y, Rountree CB, (2011) c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 54: 879-89. doi:http://dx.doi.org/10.1002/hep.24450.
54. Li Y, Li A, Glas M, Lal B, Ying M, et al. (2011) c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A 108: 9951-9956. doi:http://dx.doi.org/10.1073/pnas.1016912108.
55. You W-K, Sennino B, Williamson CW, Falcãn B, Hashizume H, et al (2011) VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res 71: 4758-4768.
56. Basak SK, Veena MS, Oh S, Huang G, Srivatsan E, et al. (2009) The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One 4: e5884.
57. You W-K, Sennino B, Williamson CW, Falcón B, Hashizume H, et al. (2011) VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res 71: 4758-4768. doi:http://dx.doi.org/10.1158/0008-5472.CAN-10-2527.
58. Whan Kim J, Gao P, Liu Y-C, Semenza GL, Dang CV, (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27: 7381-7393. doi:http://dx.doi.org/10.1128/MCB.00440-07.
59. Tacchini L, Bianchi L, Bernelli-Zazzera A, Cairo G, (1999) Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem 274: 24142-24146.
60. O'Donnell KA, Yu D, Zeller KI, Kim J-W, Racke F, et al. (2006) Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 26: 2373-2386. doi:http://dx.doi.org/10.1128/MCB.26.6.2373-2386.2006.
61. Dang CV, whan Kim J, Gao P, Yustein J, (2008) The interplay between MYC and HIF in cancer. Nat Rev Cancer 8: 51-56. doi:http://dx.doi.org/10.1038/nrc2274.
62. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V, (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32: 1-15. doi:http://dx.doi.org/10.1042/BSR20100136.
63. Cui T, Hurtig M, Elgue G, Li S-C, Veronesi G, et al. (2010) Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS ONE 5: e16010. doi:10.1371/journal.pone.0016010.
64. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:http://dx.doi.org/10.1186/gb-2004-5-10-r80.
65. Bengtsson H, Simpson K, Bullard J, Hansen K, (2008) aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Available:http://128.32.135.2/tech-reports/745.pdf. Accessed May 2012.
66. Bengtsson H, Irizarry R, Carvalho B, Speed TP, (2008) Estimation and assessment of raw copy numbers at the single locus level. Bioinformatics 24: 759-767. doi http://dx.doi.org/10.1093/bioinformatics/btn016.
67. Hupé P, Stransky N, Thiery J-P, Radvanyi F, Barillot E, (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20: 3413-3422. doi:http://dx.doi.org/10.1093/bioinformatics/bth418.
68. Guberman JM, Ai J, Arnaiz O, Baran J, Blake A, et al. (2011) BioMart Central Portal: an open database network for the biological community. Database (Oxford) 2011: bar041. doi:http://dx.doi.org/10.1093/database/bar041.
69. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432. doi:http://dx.doi.org/10.1093/bioinformatics/btq675.
70. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. doi:http://dx.doi.org/10.1038/nprot.2008.211.
71. Smyth GK, (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer pp. 397-420.
72. Therneau T, original Splus-&R port by Thomas Lumley, (2011) survival: Survival analysis, including penalised likelihood. Available:http://CRAN.R-project.org/package=survival. Accessed September 2011.